mortality/aging
|
• median survival of 35 weeks
• mice receiving intraperitoneal injections of poly(I:C), twice a week, beginning at week 5 after birth, for the duration of their lifetime to induce the activation of interferon signaling succumb to amyotrophic lateral sclerosis much later, with a median survival of 54 weeks, compared to 35 weeks in untreated mice
|
growth/size/body
|
• 16.4% weight loss, beginning at 25-29 weeks of age
|
nervous system
|
• mice show rapid development of amyotrophic lateral sclerosis, with mean onset of neurological symptoms at 31.8 weeks
• poly(I:C)-treated mice exhibit mild or no symptoms for several months
|
|
• mice exhibit large numbers of mutant protein puncta within spinal cord alpha motoneurons
• mutant protein puncta are seen in both nuclear and cytoplasmic compartments
• poly(I:C)-treated mice show a reduction of mutant protein puncta in alpha motoneurons
|
behavior/neurological
|
• grip strength shows an age-dependent, progressive decline in muscle strength and motor function
|
muscle
|
• progressive decrease in muscle strength
|
renal/urinary system


Analysis Tools